These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 24517572)
21. Development and validation of a dissolution test for lodenafil carbonate based on in vivo data. Codevilla CF; Castilhos Tdos S; Cirne CA; Froehlich PE; Bergold AM Drug Dev Ind Pharm; 2014 Apr; 40(4):488-93. PubMed ID: 23614829 [TBL] [Abstract][Full Text] [Related]
22. Validation of an HPLC-MS method for rociverine tablet dissolution analysis. Hoti E; Censi R; Ricciutelli M; Malaj L; Barboni L; Martelli S; Valleri M; Di Martino P J Pharm Biomed Anal; 2008 Jun; 47(2):422-8. PubMed ID: 18295427 [TBL] [Abstract][Full Text] [Related]
23. Spectrofluorimetric methods for the determination of gemifloxacin in tablets and spiked plasma samples. Kepekci Tekkeli SE; Önal A J Fluoresc; 2011 May; 21(3):1001-7. PubMed ID: 20981565 [TBL] [Abstract][Full Text] [Related]
24. Influence of the physiological variability of fasted gastric pH and tablet retention time on the variability of in vitro dissolution and simulated plasma profiles. Kovačič NN; Pišlar M; Ilić I; Mrhar A; Bogataj M Int J Pharm; 2014 Oct; 473(1-2):552-9. PubMed ID: 25064726 [TBL] [Abstract][Full Text] [Related]
25. Chemiluminescence determination of gemifloxacin based on diperiodatoargentate (III)-sulphuric acid reaction in a micellar medium. Zhao F; Zhao WH; Xiong W Luminescence; 2013; 28(2):108-13. PubMed ID: 22362634 [TBL] [Abstract][Full Text] [Related]
26. Dissolution method for delapril and manidipine combination tablets based on an absorption profile of manidipine. Todeschini V; Sangoi MS; Goelzer GK; Machado JC; Paim CS; Araujo BV; Volpato NM J Pharm Anal; 2016 Feb; 6(1):49-55. PubMed ID: 29403962 [TBL] [Abstract][Full Text] [Related]
27. Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose. Islinger F; Bouw R; Stahl M; Lackner E; Zeleny P; Brunner M; Müller M; Eichler HG; Joukhadar C Antimicrob Agents Chemother; 2004 Nov; 48(11):4246-9. PubMed ID: 15504848 [TBL] [Abstract][Full Text] [Related]
28. LC determination of entacapone in tablets: in vitro dissolution studies. Paim CS; Martins MT; Malesuik MD; Steppe M J Chromatogr Sci; 2010 Oct; 48(9):755-9. PubMed ID: 20875238 [TBL] [Abstract][Full Text] [Related]
29. Spectrofluorimetric determination of gemifloxacin mesylate and linezolid in pharmaceutical formulations: Application of quinone-based fluorophores and enhanced native fluorescence. Moussa BA; Mahrouse MA; Hassan MA; Fawzy MG Acta Pharm; 2014 Mar; 64(1):15-28. PubMed ID: 24670349 [TBL] [Abstract][Full Text] [Related]
30. Liquid chromatographic resolution of gemifloxacin mesylate on a chiral stationary phase derived from crown ether. Hyun MH; Han SC; Cho YJ; Jin JS; Lee W Biomed Chromatogr; 2002 Aug; 16(5):356-60. PubMed ID: 12210509 [TBL] [Abstract][Full Text] [Related]
31. Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets. Rhee YS; Park S; Lee TW; Park CW; Nam TY; Oh TO; Jeon JW; Lee DS; Park ES Arch Pharm Res; 2008 Jun; 31(6):798-804. PubMed ID: 18563364 [TBL] [Abstract][Full Text] [Related]
32. Biological safety studies of gemifloxacin mesylate and related substances. Paim CS; Nogueira DR; Mitjans M; Ramos Lopez D; de Lapuente Perez J; Steppe M; Schapoval EE; Vinardell MP Photochem Photobiol Sci; 2013 May; 12(5):805-12. PubMed ID: 23361471 [TBL] [Abstract][Full Text] [Related]
33. Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles. Menegola J; Steppe M; Schapoval EE Eur J Pharm Biopharm; 2007 Sep; 67(2):524-30. PubMed ID: 17398084 [TBL] [Abstract][Full Text] [Related]
34. Interactions between sparfloxacin and antacids - dissolution and adsorption studies. Hussain F; Arayne MS; Sultana N Pak J Pharm Sci; 2006 Jan; 19(1):16-21. PubMed ID: 16632447 [TBL] [Abstract][Full Text] [Related]
35. Development and validation of a discriminative dissolution method for atorvastatin calcium tablets using in vivo data by LC and UV methods. Machado JC; Lange AD; Todeschini V; Volpato NM AAPS PharmSciTech; 2014 Feb; 15(1):189-97. PubMed ID: 24265014 [TBL] [Abstract][Full Text] [Related]
36. Determination of gemifloxacin on dried blood spots by hydrophilic interaction liquid chromatography with fluorescence detector: application to pharmacokinetics in rats. Nageswara Rao R; Naidu ChG; Guru Prasad K; Padiya R; Agwane SB Biomed Chromatogr; 2012 Dec; 26(12):1534-42. PubMed ID: 22415905 [TBL] [Abstract][Full Text] [Related]
37. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections. Yoo BK; Triller DM; Yong CS; Lodise TP Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209 [TBL] [Abstract][Full Text] [Related]
38. Mathematical modeling of oral absorption and bioavailability of a fluoroquinolone after its precipitation in the gastrointestinal tract. Fernandez-Teruel C; Mangas-Sanjuan V; Gonzalez-Alvarez I; Ruiz-Garcia A; Casabó VG; Bermejo M Xenobiotica; 2013 Sep; 43(9):745-54. PubMed ID: 23294363 [TBL] [Abstract][Full Text] [Related]
39. Reversed phase liquid chromatography method with fluorescence detection of gemifloxacin in rat plasma and its application to the pharmacokinetic study. Kaiser M; Grünspan LD; Costa TD; Tasso L J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3639-44. PubMed ID: 21963480 [TBL] [Abstract][Full Text] [Related]
40. Spectrofluorimetric analysis of gemifloxacin mesylate in pharmaceutical formulations. Al-Tamimi SA; Alarfaj NA; Aly FA; Al-Mohaimeed AM Luminescence; 2014 Mar; 29(2):127-31. PubMed ID: 23681953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]